Your browser doesn't support javascript.
loading
Is Ki67 prognostic for aggressive prostate cancer? A multicenter real-world study.
Fantony, Joseph J; Howard, Lauren E; Csizmadi, Ilona; Armstrong, Andrew J; Lark, Amy L; Galet, Colette; Aronson, William J; Freedland, Stephen J.
Afiliación
  • Fantony JJ; Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.
  • Howard LE; Urology Section, Durham Veterans Affairs Medical Center, Durham, NC 27705, USA.
  • Csizmadi I; Department of Biostatistics and Bioinformatics, Duke School of Medicine, Durham, NC 27705, USA.
  • Armstrong AJ; Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
  • Lark AL; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA.
  • Galet C; Department of Pathology, Duke University Hospital, Durham, NC 27710, USA.
  • Aronson WJ; Department of Pathology, Durham Veterans Affairs Medical Center, Durham, NC 27710, USA.
  • Freedland SJ; Department of Urology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA.
Biomark Med ; 12(7): 727-736, 2018 07.
Article en En | MEDLINE | ID: mdl-29902938

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Antígeno Ki-67 Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male / Middle aged Idioma: En Revista: Biomark Med Asunto de la revista: BIOQUIMICA / MEDICINA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Antígeno Ki-67 Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male / Middle aged Idioma: En Revista: Biomark Med Asunto de la revista: BIOQUIMICA / MEDICINA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos